Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
70,886,873
-
Number of holders
-
168
-
Total 13F shares, excl. options
-
40,380,352
-
Shares change
-
+2,008,115
-
Total reported value, excl. options
-
$1,757,762,073
-
Value change
-
+$87,929,967
-
Put/Call ratio
-
6.6%
-
Number of buys
-
105
-
Number of sells
-
-52
-
Price
-
$43.53
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q4 2020
185 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q4 2020.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40,380,352 shares
of 70,886,873 outstanding shares and own 57% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2,884,632 shares), Capital Research Global Investors (2,882,700 shares), WELLINGTON MANAGEMENT GROUP LLP (2,848,597 shares), BlackRock Inc. (2,531,400 shares), FMR LLC (2,100,635 shares), Clearbridge Investments, LLC (1,939,464 shares), ALLIANCEBERNSTEIN L.P. (1,730,845 shares), JANUS HENDERSON GROUP PLC (1,437,694 shares), Capital International Investors (1,335,737 shares), and VICTORY CAPITAL MANAGEMENT INC (1,146,358 shares).
This table shows the top 168 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.